SCHEMBL23629645

SCHEMBL23629645

O=C(O)Cn1nc(I)c2cc(Br)cc([N+](=O)[O-])c21

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.44
GPR35 Q9HC97 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
HTT P42858 1/20 0.35
ERN1 O75460 1/20 0.34
LMNA P02545 2/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.32
S100A4 P26447 1/20 0.32
TRPV1 Q8NER1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26679679 0.84 ALDH1A1 (0.34) FBP1ALDH1A1MEN1MAPTKMT2A
SCHEMBL20488677 0.79 LMNA (0.43) ALDH1A1L3MBTL1LMNARAB9A
SCHEMBL20487380 0.79 LMNA (0.43) ALDH1A1L3MBTL1LMNARAB9AKDM4E
SCHEMBL20488486 0.75 EPRS1 (0.37) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL20487613 0.73 LMNA (0.35) ALDH1A1L3MBTL1LMNA
SCHEMBL26679676 0.69 ALDH1A1 (0.33) FBP1ALDH1A1MEN1MAPTKMT2A
SCHEMBL20489090 0.69 KRAS (0.32) LMNA
SCHEMBL25930458 0.67 NPC1 (0.36) ALDH1A1MAPTKMT2ASMN1; SMN2PKM
SCHEMBL20487623 0.65 TSHR (0.39) ALDH1A1MAPTKMT2ASMN1; SMN2HTT
SCHEMBL18862781 0.65 ERN1 (0.50) FBP1GPR35ALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3846803-A2 MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS Achillion Pharmaceuticals, Inc. (US) 2021-07-14 EP disclosed